Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: B03AB

Feraccru(ferric maltol)

Anemia, Iron-Deficiency

Marketing Authorisation Holder: Norgine B.V.

EMA Authorisation: 18/02/2016

INN: ferric maltol

Indication

Feraccru is indicated in adults for the treatment of iron deficiency.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Feraccru — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.